Circulating KL-6 levels in patients with drug induced pneumonitis.

@article{Ohnishi2003CirculatingKL,
  title={Circulating KL-6 levels in patients with drug induced pneumonitis.},
  author={Hirohumi Ohnishi and Akihito Yokoyama and Yumiko Yasuhara and Akira Watanabe and Teiji Naka and Hiromi Hamada and Masato Abe and Koichi Nishimura and Jituo Higaki and Junpei Ikezoe and Nobuoki Kohno},
  journal={Thorax},
  year={2003},
  volume={58 10},
  pages={
          872-5
        }
}
BACKGROUND The circulating level of KL-6/MUC1 is a sensitive marker for various interstitial lung diseases. Previous case reports have suggested that KL-6 may also be increased in some patients with drug induced pneumonitis. A study was undertaken to determine whether serum KL-6 could be a marker for particular types of drug induced pneumonitis. METHODS The findings of high resolution computed tomographic (HRCT) chest scans of 30 patients with drug induced pneumonitis were reviewed separately… CONTINUE READING
Highly Cited
This paper has 25 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 16 citations

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Diseases characterized primarily by linear and reticular opacities

  • WR Webb, NL Müller, DP. Naidich
  • Highresolution CT of the lung,
  • 2001

Drugs. In: Fraser RS, Müller NL, Colman N, eds. Fraser and Paré’s diagnosis of diseases of the chest, 4th ed. Philadelphia: WB Saunders, 1999:2537–83

  • RS Fraser, NL Müller, N Colman
  • eds. Katzenstein and Askin’s surgical pathology…
  • 1999

Pathology of drug - induced lung disease

  • JL Myers
  • Fraser and Paré ’ s diagnosis of diseases of the…
  • 1999